UK warned over unregulated experimental peptide market
An expert has warned that the UK is becoming a 'wild west' for unregulated experimental peptides, which are being sold and used without proper oversight. This lack of regulation poses significant health risks as these substances are not approved for safety or efficacy. The warning highlights growing concerns about gaps in drug regulation and public safety.